热塑体膜双重标记联合开窗技术定位在乳腺癌保乳术后放疗中的应用价值

Application value of thermoplastic membrane double labeling combined with fenestration technology in post-breast conserving radiotherapy for breast cancer

  • 摘要:
    目的 比较乳腺癌患者保乳术后采用乳腺托架定位与基于热塑体膜双重标记联合开窗技术定位方式的放疗摆位误差及放射性皮肤反应,对热塑体膜双重标记联合开窗技术定位方法的可行性进行研究。
    方法 回顾性分析2019年1月至2020年12月郑州大学第五附属医院收治的83例乳腺癌保乳术后女性患者的临床资料,年龄(47.5±10.1)岁。根据定位方式将患者分为乳腺托架组(41例)和体膜组(42例),2组患者在放疗前通过直线加速器在机载锥形束 CT(CBCT)下进行摆位验证。根据美国肿瘤放射治疗协作组制定的标准评估入组患者的急性和晚期放射性皮肤反应。摆位误差的组间比较采用t检验;计数资料的组间比较采用χ2检验。
    结果 体膜组在左右(X轴)(2.14±0.19) mm对(2.96±0.20) mm、头脚(Y轴)(2.49±0.15) mm对(3.05±0.16) mm、腹背(Z轴)(2.41±0.22) mm对(3.14±0.19) mm方向的摆位误差明显小于乳腺托架组(t=2.98、2.63、2.49,均P<0.05);且在摆位误差≤3 mm时,Y轴方向体膜组分布比例高于乳腺托架组(72.20%对48.78%,χ2=7.23,P=0.01);在摆位误差>5 mm时,X轴(3.81%对8.78%)、Y轴(8.78%对33.17%)、Z轴(10.95%对24.88%)方向体膜组分布比例均低于乳腺托架组(χ2=4.37、12.40、13.73,均P<0.05);2组患者急性放射性皮肤反应发生率(30.95%对53.66%)的差异有统计学意义(χ2=4.39,P=0.04)。
    结论 基于热塑体膜双重标记联合开窗技术定位方式减小了摆位误差、减轻了急性放射性皮肤反应,具有较好的稳定性和重复性,更安全可靠,且操作简捷。

     

    Abstract:
    Objective To compare the radiotherapy positioning error and radiation skin response of post-breast conserving radiotherapy patients with breast cancer using breast bracket positioning and thermoplastic membrane double labeling combined with fenestration technology. The feasibility of the positioning method based on thermoplastic-membrane double labeling combined with fenestration technology was also explored.
    Methods The clinical data of 83 female patients post-breast conserving radiotherapy for breast cancer after breast-conserving surgery at the Fifth Affiliated Hospital of Zhengzhou University from January 2019 to December 2020 were retrospectively analyzed. The patients were aged (47.5±10.1) years. According to the positioning method, they were divided into breast-bracket group (41 cases) and body-membrane group (42 cases). Two groups of patients underwent positioning verification using a linear accelerator under airborne cone-beam CT before radiotherapy. Evaluated the acute and late radiation skin reactions in enrolled patients according to the standards established by the Radiation Therapy Oncology Group of United States. Intergroup comparison of the positioning error was conducted using the t-test, and intergroup comparison of the counting data was conducted using the chi-square test.
    Results Positioning errors in the left and right (X-axis) (2.14±0.19) mm vs. (2.96±0.20) mm, head and foot (Y-axis) (2.49±0.15) mm vs. (3.05±0.16) mm, and abdominal back (Z-axis)(2.41±0.22) mm vs. (3.14±0.19) mm directions of the body-membrane group were significantly lower than those of the breast-bracket group (t=2.98, 2.63, and 2.49, respectively; all P<0.05). When the positioning error was ≤3 mm, the distribution proportion of the body-membrane group in the Y-axis direction was higher than that of the breast-bracket group (72.20% vs. 48.78%; χ2=7.23, P=0.01), when the positioning error was >5 mm, the distribution proportion of body membrane in the X-axis(3.81% vs. 8.78%), Y-axis (8.78% vs. 33.17%), and Z-axis (10.95% vs. 24.88%) groups was lower than that of the breast-bracket group (χ2=4.37, 12.40, and 13.73, respectively; all P<0.05). The incidence of acute radiation skin reaction was significantly different between the two groups (30.95% vs. 53.66%; χ2=4.39, P=0.04).
    Conclusions The thermoplastic membrane double labeling combined with fenestration technology reduces the positioning error and alleviates acute radioactive skin reaction. It also has better stability and repeatability, is safer and more reliable, and is easy to operate.

     

/

返回文章
返回